Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Experimental & Molecular Medicine ; : 150-155, 2001.
Article in English | WPRIM | ID: wpr-215631

ABSTRACT

Extracellular ATP has been known to modulate various cellular responses including mitogenesis, secretion and morphogenic activity in neuronal cells. In the ATP-induced morphogenic activity, focal adhesion kinase(s) such as Fak have been suggested to play a critical role. Binding of ATP to its specific cell surface receptor in PC12 cells induces phospholipase D (PLD) activity. However, the role of PLD on ATP-induced Fak activation in PC12 cells remains unclear. In this study, we investigated the role of PLD on the ATP-induced Fak activation and paxillin phosphorylation using two established cell lines: wild type PLD2- and lipase-inactive mutant PLD2-inducible PC12 cells. Stimulation of cells with ATP caused PLD2 activation via classical protein kinase C activation. ATP also induced Fak activation, and paxillin phosphorylation, and were dramatically reduced by wild type PLD2 overexpression but not by lipase-inactive mutant PLD2 overexpression. When the PC12 cells were pretreated with propranolol, a specific inhibitor for phosphatidic acid phosphohydrolase resulting in the accumulation of PA, ATP-induced Fak activation and paxillin phosphorylation were also reduced. We found that inhibition of tyrosine phosphatases by pervanadate completely blocked PLD2-dependent Fak and paxillin dephosphorylation. Taken together, we suggest that PLD2 activity might play a negative role in ATP-induced Fak and paxillin phosphorylation possibly through tyrosine phosphatases.


Subject(s)
Rats , Adenosine Triphosphate/metabolism , Animals , Culture Media, Serum-Free , Cytoskeletal Proteins/metabolism , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Focal Adhesions/metabolism , PC12 Cells , Phospholipase D/metabolism , Phosphoproteins/metabolism , Phosphorylation , Propranolol/pharmacology , Protein Kinase C/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL